Comparison of Maximal Oxygen Uptake Obtained Via Seismofit and Cardiopulmonary Exercise Test

April 21, 2026 updated by: Zachary Townsend, Salisbury University
This study aims to validate the Ventriject Seismofit device by comparing VO2 Max obtained via the Seismofit and traditional Cardiopulmonary Exercise Testing.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Maryland
      • Salisbury, Maryland, United States, 21801
        • Salisbury University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Healthy adults in Maryland

Description

Inclusion Criteria:

  • Healthy adults 18-65 years old
  • Provide health history questionnaire and informed consent

Exclusion Criteria:

  • Known chronic disease (cardiovascular, pulmonary, and/or metabolic disease)
  • Orthopedic Concern
  • Acute illness during day of test
  • Severe Hypertension (SBP >200 and/or DBP > 110) at rest
  • Reported pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
VO2 Max
Time Frame: Cross-sectional data collected at one time. Total data collection will occur over 3 months.
Maximal oxygen uptake obtained via Cardiopulmonary Exercise Test on a cycle, as well as the Seismofit at rest.
Cross-sectional data collected at one time. Total data collection will occur over 3 months.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body Fat %
Time Frame: Cross-sectional data collected at one time. Total data collection will occur over 3 months.
Body Fat % will be obtained via Bod Pod.
Cross-sectional data collected at one time. Total data collection will occur over 3 months.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Salisbury University

Collaborators

VentriJect ApS

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 9, 2025

Primary Completion (Actual)

December 1, 2025

Study Completion (Actual)

December 5, 2025

Study Registration Dates

First Submitted

April 21, 2026

First Submitted That Met QC Criteria

April 21, 2026

First Posted (Actual)

April 28, 2026

Study Record Updates

Last Update Posted (Actual)

April 28, 2026

Last Update Submitted That Met QC Criteria

April 21, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 491

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on VO2 Max

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Armenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe